Table 1 Baseline characteristics of study patients
Variable | Total (n = 88) |
|---|---|
Age (years) | 60.6 ± 13.5 |
Gender, male, n (%) | 50 (56.8) |
Diabetic, n (%) | 50 (56.8) |
Cause of ESRD, n (%) | |
 Diabetes | 48 (54.5) |
 Hypertension | 21 (23.9) |
 Glomerulonephritis | 11 (12.5) |
 Others | 8 (9.1) |
MAP (mmHg) | 103.9 ± 11.0 |
Dialysis vintage (months) | 50.8 ± 41.3 |
HD access type, n (%) | |
 Arteriovenous fistula | 53 (60.2) |
 Arteriovenous graft | 35 (39.8) |
CAD, n (%) | 27 (23.8) |
CVD, n (%) | 21 (23.9) |
PAOD, n (%) | 7 (8.0) |
Hemoglobin (g/dL) | 9.7 ± 1.5 |
Glucose (mg/dL) | 110.6 ± 63.3 |
Albumin (g/dL) | 3.4 ± 0.4 |
Prealbumin (mg/dL) | 26.6 ± 7.7 |
Uric acid (mg/DL) | 7.8 ± 2.1 |
25-OH Vitamin D (ng/mL) | 9.6 ± 4.7 |
intact PTH (pg/mL) | 177.2 ± 244.1 |
Iron (μg/dL) | 73.1 ± 31.1 |
Transferrin (μg/dL) | 192.3 ± 44.1 |
Transferrin saturation (%) | 44.5 ± 21.7 |
Ferritin (ng/mL) | 201.0 ± 118.0 |
Total cholesterol (mg/dL) | 140.8 ± 36.7 |
LDL (mg/dL) | 79.6 ± 26.8 |
HDL (mg/dL) | 44.2 ± 10.9 |
Triglyceride (mg/dL) | 90.2 ± 48.7 |
β2-microglobulin (mg/L) | 26.3 ± 7.7 |
Kt/V | 1.5 ± 2.4 |
nPCR | 1.1 ± 0.3 |
hs-CRP (mg/L) | 1.0 (0.4–2.6) |